Literature DB >> 11472731

Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system.

N Fournier1, V Atger, A Cogny, B Vedie, P Giral, A Simon, N Moatti, J L Paul.   

Abstract

The high triglyceride/low HDL-cholesterol trait is a common finding in the general population. The aim of the present study was to analyze and interpret the relationships between triglycerides (TG), HDL-related parameters and serum cholesterol efflux potential in an asymptomatic population including both normo- and hyperlipidemic individuals. In a large sample (n = 1143) of this population, there was a negative correlation between TG and HDL-cholesterol (HDL-C) (r = -0.49, P<0.0001) whereas the negative correlation between TG and HDL-phospholipid (HDL-PL) (r = -0.29, P<0.0001) was weaker, leading to a strong positive correlation between TG and HDL-PL/C ratio (r = 0.58, P<0.0001). Thus, increased TG concentrations were associated with an enrichment of HDL with PL. Since we have demonstrated previously that HDL-PL is the major determinant for cholesterol efflux potential from Fu5AH rat hepatoma cells, we determined the effect of the variations in HDL lipid composition on the cholesterol efflux capacity in a subsample of 198 subjects. Compared with normolipidemic subjects (NLP) (TG< or = 1.7 mmol/l; LDL-C< or = 4.1 mmol/l, n=58), hypertriglyceridemic subjects (HTG) (TG>1.7 mmol/l, n=63) exhibited lower HDL-C levels (1.08+/-0.21 vs. 1.25+/-0.32, P=0.0003) whereas they showed similar HDL-PL concentrations (1.25+/-0.21 vs. 1.25+/-2.7) and, thus, higher HDL-PL/C ratio (1.17+/-0.15 vs. 1.02+/-0.14, P=0.0001). The relative efflux capacity of serum measured in the Fu5AH system (5% serum, 4 h incubation at 37 degrees C) was on average identical in the HTG and NLP groups. Thus, this study provides evidence that despite decreased HDL concentrations, as determined routinely by the HDL-C assay, some HTG subjects maintained serum cholesterol efflux capacity thanks to the enrichment of HDL with PL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472731     DOI: 10.1016/s0021-9150(00)00730-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Authors:  Fabiana Rached; Raul D Santos; Laurent Camont; Marcio H Miname; Marie Lhomme; Carolane Dauteuille; Sora Lecocq; Carlos V Serrano; M John Chapman; Anatol Kontush
Journal:  J Lipid Res       Date:  2014-10-23       Impact factor: 5.922

2.  Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.

Authors:  Madhuri Vasudevan; Urbain Tchoua; Baiba K Gillard; Peter H Jones; Christie M Ballantyne; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2013-05-25       Impact factor: 4.766

3.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

4.  A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.

Authors:  Norman A Mazer; Franco Giulianini; Nina P Paynter; Paul Jordan; Samia Mora
Journal:  Clin Chem       Date:  2013-02-20       Impact factor: 8.327

5.  HDL superphospholipidation enhances key steps in reverse cholesterol transport.

Authors:  Urbain Tchoua; Baiba K Gillard; Henry J Pownall
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

6.  High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy.

Authors:  Laxman Yetukuri; Ilkka Huopaniemi; Artturi Koivuniemi; Marianna Maranghi; Anne Hiukka; Heli Nygren; Samuel Kaski; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Orešič
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

7.  Sesamum indicum diet prevents hyperlipidemia in experimental rats.

Authors:  Muinat M Adeyanju; Idris A Saheed; Oluwaseun I Oyelekan; Taiwo A Dele-Osibanjo; Ayodeji A Adelegan; Adekunle J Raimi; Samuel O Olalekan; Olugbenga S Alabi; Khadijat M Alli
Journal:  Food Chem (Oxf)       Date:  2022-03-07

8.  Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet.

Authors:  Fatima Kasbi Chadli; Hassane Nazih; Michel Krempf; Patrick Nguyen; Khadija Ouguerram
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

9.  A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity.

Authors:  Shigemasa Tani; Rei Matsuo; Kenji Kawauchi; Tsukasa Yagi; Wataru Atsumi; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2017-11-20       Impact factor: 2.037

10.  D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.

Authors:  Sophie Valleix; Guglielmo Verona; Noémie Jourde-Chiche; Brigitte Nédelec; P Patrizia Mangione; Frank Bridoux; Alain Mangé; Ahmet Dogan; Jean-Michel Goujon; Marie Lhomme; Carolane Dauteuille; Michèle Chabert; Riccardo Porcari; Christopher A Waudby; Annalisa Relini; Philippa J Talmud; Oleg Kovrov; Gunilla Olivecrona; Monica Stoppini; John Christodoulou; Philip N Hawkins; Gilles Grateau; Marc Delpech; Anatol Kontush; Julian D Gillmore; Athina D Kalopissis; Vittorio Bellotti
Journal:  Nat Commun       Date:  2016-01-21       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.